Novo Integrated Sciences, Inc. (NVOS)
| Market Cap | 13.80M |
| Revenue (ttm) | 12.57M |
| Net Income (ttm) | -13.21M |
| Shares Out | 16.81M |
| EPS (ttm) | -1.30 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,723,267 |
| Open | 0.840 |
| Previous Close | 0.806 |
| Day's Range | 0.660 - 0.867 |
| 52-Week Range | 0.660 - 5.380 |
| Beta | -0.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Dec 14, 2023 |
About NVOS
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline test... [Read more]
Financial Performance
In 2023, NVOS's revenue was $12.57 million, an increase of 7.11% compared to the previous year's $11.74 million. Losses were -$13.21 million, -59.77% less than in 2022.
Financial StatementsNews
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences.
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results.
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India.
Novo Integrated Sciences' Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval.
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement.
Novo Integrated Sciences Announces Reverse Stock Split
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Announces Reverse Stock Split.
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days.
Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond.
Novo Integrated Sciences' Board of Directors Approves $5 Million Stock Repurchase Program
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' Board of Directors Approves $5 Million Stock Repurchase Program.
Top 3 penny stocks to day trade: HUBC, TTOO, NVOS
Penny stocks are highly popular among day and swing traders because of their low prices and volatility. Most of these stocks are usually bad long-term investments because of their unprofitability, esp...
Novo Integrated Sciences Provides Update on Certain Current Events
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Provides Update on Certain Current Events.
NVOS stock price is surging but Novo Integrated is still risky
Novo Integrated Sciences (NASDAQ: NVOS) stock price surged by more than 86% in the pre-market session to a high of $0.38, the highest level since September 18th. It has surged by more than 92% from th...
Novo Integrated stock more than doubles after hours on $1 billion collateral agreement
Novo Integrated Sciences Inc. NVOS shares more than doubled in the extended session Thursday after the tiny healthcare company said it or entered a $1 billion funding agreement for the next 15 years. ...
Novo Integrated Sciences Signs Master Collateral Transfer Agreement
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Signs Master Collateral Transfer Agreement. One Billion Dollar Collateral Transfer through Blacksheep Trust.
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Provides Update on Certain Current Actions and Events. September 29, 2023 Shareholder Meeting Voting Update.
Novo Integrated Sciences' IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey's Ministry of Health
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey's Ministry of Health.
Novo Integrated Sciences Provides Update on Potential Share Repurchase Program
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Provides Update on Potential Share Repurchase Program.
Novo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 Coupon
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company received an Underwriting Clearance Notice from RC...
Acenzia Selected to join Team Canada Trade Mission to India
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that Acenzia, a nutraceutical manufacturer and a Canadian sub...
Novo Integrated Sciences' IoNovo Iodine Granted Registration Number and Regulatory Approval by Turkey's Ministry of Health
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that its IoNovo Iodine product has been granted a registratio...
Novo Integrated Sciences and Farm 7 Group Announce Joint Venture for Kenya Cooperative Agricultural Project
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced the Company and Farm 7 Group Inc., a Canada corporation (“F7”)...
Novo Integrated Sciences Reports Fiscal Year 2023 Third Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a ...
Novo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in Canada
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in Canada.
Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results.
Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results.